May 27, 2026 · Form 4 insider transaction
Farid Ramy bought 8,000 shares of Vir Biotechnology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.; The RSUs will vest in full on May 27, 2027.